Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Masimo Corporation specializes in noninvasive monitoring technologies, primarily focused on pulse oximetry and advanced noninvasive monitoring solutions. The company's competitive position is bolstered by its proprietary Signal Extraction Technology, which enhances accuracy in measuring blood oxygen levels, particularly in challenging patient conditions. Its products are widely used in hospitals and critical care settings across North America and Europe.
Masimo generates revenue primarily through the sale of its proprietary monitoring devices and associated consumables, which are essential for ongoing patient care. The company benefits from high gross margins due to its advanced technology and the recurring nature of consumable sales, which creates a stable revenue stream.
Adoption rates of Masimo's noninvasive monitoring technologies in hospitals
Regulatory approvals for new products or technology enhancements
Trends in healthcare spending and hospital budgets
Competitive advancements from rivals like Philips and GE Healthcare
Technological disruption from emerging monitoring technologies
Regulatory changes impacting medical device approvals
Increased competition from established players and new entrants
Potential for price erosion in the medical device market
Moderate debt levels could constrain financial flexibility in downturns
Potential liquidity risks if cash flow does not improve
moderate - Masimo's performance is somewhat linked to healthcare spending, which can be influenced by GDP growth and consumer spending on health services.
Interest rates affect Masimo primarily through the cost of capital for R&D and expansion. Higher rates could dampen investment in new technologies, impacting growth.
minimal - Masimo operates with a manageable debt level and does not heavily rely on credit for its operations.
growth - Investors are likely attracted to Masimo for its innovative technology and potential for revenue growth in the healthcare sector.
moderate - The stock has shown moderate volatility, reflecting both market conditions and company-specific developments.